763 results on '"Donnelly, Paul S."'
Search Results
2. Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE
3. Evidence for disrupted copper availability in human spinal cord supports CuII(atsm) as a treatment option for sporadic cases of ALS
4. Microglial ferroptotic stress causes non-cell autonomous neuronal death
5. Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis
6. Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo
7. Assessment of the epi-pericardial fibrotic substrate by collagen-targeted probes
8. Quantum magnetic resonance microscopy
9. Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of 225Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.
10. Harnessing 64 Cu/ 67 Cu for a theranostic approach to pretargeted radioimmunotherapy
11. Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models
12. Diagnostic Positron Emission Tomography Imaging with Zirconium-89 Desferrioxamine B Squaramide: From Bench to Bedside
13. Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer’s Disease
14. Examination of N,N-dimethylbenzylamine as a substrate for ruthenium-catalysed C-H (thio)amidation: A mass spectrometry and DFT directed study
15. Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE.
16. Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX
17. Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice
18. CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1G93A mice with a C57BL/6 background
19. Metallic radionuclides for diagnostic imaging and cancer radiotherapy: The development of theragnostic matched pairs and targeted alpha therapy
20. Desulfination versus decarboxylation as a means of generating three- and five-coordinate organopalladium complexes [(phen)nPd(C6H5)]+ (n = 1 and 2) to study their fundamental bimolecular reactivity
21. Labelling proteins and peptides with phosphorescent d6 transition metal complexes
22. Evidence for disrupted copper availability in human spinal cord supports CuII(atsm) as a treatment option for sporadic cases of ALS.
23. Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides
24. A patient–derived blood–brain barrier model for screening copper bis(thiosemicarbazone) complexes as potential therapeutics in Alzheimer's disease
25. Copper(II) Complexes of 2,2′-Bisdipyrrins: Synthesis, Characterization, Cell Uptake, and Radiolabeling with Copper-64
26. Cu(ATSM) Increases P-Glycoprotein Expression and Function at the Blood-Brain Barrier in C57BL6/J Mice
27. Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®
28. Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation
29. Correction to: Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models
30. PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study
31. Rhenium and technetium complexes of thioamide derivatives of pyridylhydrazine that bind to amyloid-β plaques
32. A General Fluorescence-Based Method for Quantifying and Mapping Biomolecular Polarity In Vitro and In Cells
33. A gallium(III) Schiff base-curcumin complex that binds to amyloid-β plaques
34. Inert Transition Metal Ion Complexes in Organic Synthesis: Protection and Activation.
35. A cis-β-iron(III) SALPN catalyst for hydrogen atom transfer reductions and olefin cross couplings.
36. Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease
37. Transdermal Application of Soluble CuII(atsm) Increases Brain and Spinal Cord Uptake Compared to Gavage with an Insoluble Suspension
38. ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol
39. The Copper bis(thiosemicarbazone) Complex CuII(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu
40. Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone–Pyridylhydrazone Copper(II) Complex
41. Palladium-Mediated CO2 Extrusion Followed by Insertion of Allenes: Translating Mechanistic Studies to Develop a One-Pot Method for the Synthesis of Alkenes
42. Diagnostic imaging of Alzheimer's disease with copper and technetium complexes
43. An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copper II
44. Microglial ferroptotic stress causes non-cell autonomous neuronal death
45. Copper bis(thiosemicarbazone) complexes modulate P‐glycoprotein expression and function in human brain microvascular endothelial cells
46. An icosanuclear silver(I) cluster supported by bis(thiosemicarbazonato) ligands
47. The role of silver carbonate as a catalyst in the synthesis of
48. Macrocyclic Bifunctional Chelators and Conjugation Strategies for Copper-64 Radiopharmaceuticals
49. Investigation of brain metabolite profiles in Cu II (gtsm) treated APdE9 mice modelling Alzheimer's disease
50. Electron paramagnetic resonance microscopy using spins in diamond under ambient conditions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.